Industry Spotlight: Adaptive Biotechnologies

Susan Thornton, CLF CEO, had the chance to sit down with Dr. Ilan “Lanny” Kirsch, Senior VP of Translational Medicine at Adaptive Biotechnologies, the creators of an innovative diagnostic tool that can be used in cutaneous lymphoma.  Because cutaneous lymphoma is challenging to diagnose, especially in early stage disease, finding new ways of diagnosing and following the disease is vitally important.  Learn more about this new diagnostic technology in this discussion.

Read more about how this diagnostic tool has been used in cutaneous lymphoma research projects conducted by the cutaneous lymphoma team at Dana Farber Cancer Institute.  

The CLF played an important funding role in supporting this research through its CLARIONS research grant program. You can read about these projects in our annual Research Reports